Pricing Log in Create free account
Saturday 17 October 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.48%, free cash flow grew 17.4% and total debt rose 37.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

79.20 0.78 +0.99%
Market cap
$32.4B
P/E
13.0×
Fwd P/E
12.3×
Dividend yield
2.64%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zoetis Inc. (ZTS) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Zoetis Inc. (ZTS) trades at a EV/FCF of 18.0×. Over the past ten years it has ranged from 16.1× (October 2026) to 72.8× (August 2023); the current reading is higher than 3% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 27.9× (18.36%)
FY2024 34.2× (41.76%)
FY2023 58.7× 6.47%
FY2022 55.1× (19.39%)
FY2021 68.4× 40.83%
FY2020 48.6× (2.83%)
FY2019 50.0× 63.64%
FY2018 30.6× (9.90%)
FY2017 33.9× (34.33%)
FY2016 51.6× (17.49%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 16.6× (35.91%)
Mar 2026 26.0× (6.98%)
Dec 2025 27.9× (12.10%)
Sep 2025 31.8× (3.39%)
42 more quarters

Against its own ten years

Low 16.1× High 72.8×
Ten-year median 50.0×
Current reading's percentile 3

EV/FCF against peers

Company EV/FCF
TAK Takeda Pharmaceutical Co. compare 12.1×
HLN Haleon PLC Sponsored ADR compare 12.4×
NBIX Neurocrine Biosciences, Inc. compare 15.9×
ZTS Zoetis Inc. 18.0×
VTRS Viatris Inc. compare 18.1×
UTHR United Therapeutics Corporation compare 18.7×
ELAN Elanco Animal Health Incorporated compare 42.4×
TEVA Teva Pharmaceutical Industries Ltd. compare 43.8×
RDY Dr. Reddy's Laboratories Ltd compare 72.8×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on ZTS